Israel’s Teva To Donate Millions Of Doses Of Potential Coronavirus Drug Treatment
The Israeli pharmaceutical giant says it will send some 6 million tablets of hydroxychloroquine sulfate, an FDA-approved malaria drug, to US hospitals.
March 22, 2020
Teva Teams Up With TAU, Weizmann Institute For Early-Stage Cancer Drug Research
The Israeli pharmaceutical giant signed separate agreements with the universities for innovative drug research and development with a focus on cancer treatments.
November 26, 2019
FDA Grants Approval For Teva’s Generic Nasal Spray For Opioid Overdoses
Teva's is the first generic naloxone hydrochloride nasal spray approved by the FDA.
April 21, 2019
Technion Launches New Center For Entrepreneurship And Innovation
The prestigious university won a government grant to establish t-hub, a new center that will become a focal point for all the entrepreneurial activities of Technion faculties
November 12, 2018
Troubled Teva Appoints New CEO In Bid For Direction
Kåre Schultz, former chief executive at H. Lundbeck A/S, to steer Israeli drugmaker to divest assets, cut debt and restore investor confidence
September 26, 2017
Teva CEO Erez Vigodman Resigns
February 7, 2017 | Teva Pharmaceutical Industries Ltd. announced last night that CEO Erez Vigodman has resigned. He will be replaced as interim president and CEO by Dr. Yitzhak Peterburg, who has served as Chairman of the Teva Board of Directors since January 2015. Vigodman’s sudden departure is unexpected but not entirely surprising. The world’s largest generic […]
February 07, 2017
‘Teva’ Launches Generic Drug Against Depression
Teva Pharmaceutical Industries launched its generic version of Forest Laboratories’ Lexapro, for the treatment of depression and generalized anxiety disorder. Teva will enjoy six months of marketing exclusivity, as it was the first company to file an Abbreviated New Drug Application with the FDA. Lexapro has been a major revenue generator for Forest Labs with the […]
March 15, 2012
‘Teva’: Positive Results In Phase III Trial For Rhinitis Nasal Spray
Teva Pharmaceutical Industries reported positive results from Phase III clinical studies for its QNASL nasal spray. The spray is designed to treat seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR). The trials tested the efficacy and safety of the spray, as well as the impact on quality of life. The results were reported at […]
March 06, 2012
Teva Launches Generic Prometrium
Teva has launched a generic version of Prometrium capsules for the treatment of secondary amenorrhea, a cessation in menstrual periods for more than six months. The illness is due to a decrease in the hormone progesterone. The drug is also given to menopausal women together with estrogen-containing medications.
March 04, 2012